BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25982135)

  • 1. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan.
    Fadoo Z; Nisar I; Yousuf F; Lakhani LS; Ashraf S; Imam U; Zaheer J; Naqvi A; Belgaumi A
    Pediatr Blood Cancer; 2015 Oct; 62(10):1700-8. PubMed ID: 25982135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA).
    Al-Mulla NA; Chandra P; Khattab M; Madanat F; Vossough P; Torfa E; Al-Lamki Z; Zain G; Muwakkit S; Mahmoud S; Al-Jassmi A; Tuncer M; Al-Mukharraq H; Barsaoui S; Arceci RJ; Howard SC; Kulozik AE; Ravindranath Y; Reaman GH; Farranoush M; AlNasser AA
    Pediatr Blood Cancer; 2014 Aug; 61(8):1403-10. PubMed ID: 24648275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
    Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
    Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    Gao C; Zhao XX; Li WJ; Cui L; Zhao W; Liu SG; Yue ZX; Jiao Y; Wu MY; Li ZG
    Am J Hematol; 2012 Nov; 87(11):1022-7. PubMed ID: 22911440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries.
    Siddiqui R; Nancy N; Naing WP; Ali S; Dar L; Khan BK; Padua RA; Carr R
    Cancer Genet Cytogenet; 2010 Jul; 200(2):149-53. PubMed ID: 20620598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of modified St Jude total therapy 13A for childhood acute lymphoblastic leukemia in the southeast region of Turkey.
    Koc A; Aycicek A; Ozdemir ZC; Soker M; Varma M
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):36-41. PubMed ID: 23138117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study.
    Yeoh AE; Ariffin H; Chai EL; Kwok CS; Chan YH; Ponnudurai K; Campana D; Tan PL; Chan MY; Kham SK; Chong LA; Tan AM; Lin HP; Quah TC
    J Clin Oncol; 2012 Jul; 30(19):2384-92. PubMed ID: 22614971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
    Lemez P; Attarbaschi A; Béné MC; Bertrand Y; Castoldi G; Forestier E; Garand R; Haas OA; Kagialis-Girard S; Ludwig WD; Matutes E; Mejstríková E; Pages MP; Pickl W; Porwit A; Orfao A; Schabath R; Starý J; Strobl H; Talmant P; van't Veer MB; Zemanová Z;
    Eur J Haematol; 2010 Oct; 85(4):300-8. PubMed ID: 20561032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Hsiao CC; Lin KH; Sheen JM; Cheng CN; Wu KH; Lin SW; Yu SL; Chen HY; Lu MY; Chang HH; Yen CT; Lin JF; Su YH; Li YP; Lin CY; Jou ST; Lin DT
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e323-30. PubMed ID: 20930648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of childhood acute lymphoblastic leukemia in Jordan.
    Halalsheh H; Abuirmeileh N; Rihani R; Bazzeh F; Zaru L; Madanat F
    Pediatr Blood Cancer; 2011 Sep; 57(3):385-91. PubMed ID: 21360658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
    Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
    Liang DC; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Peng CT; Lin MT; Chang TK; Jaing TH; Liu HC; Wang LY; Yeh TC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Wu KH; Hung GY; Chen RL; Chen SH; Cheng SN; Chang YH; Chen BW; Ho WL; Wang JL; Lin ST; Hsieh YL; Wang SC; Chang HH; Yang YL; Huang FL; Chang CY; Chang WH; Lin KS
    Leukemia; 2010 Feb; 24(2):397-405. PubMed ID: 20016538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response rate of Pakistani children with acute lymphoblastic leukaemia to Medical Research Council acute lymphoblastic leukaemia 97 chemotherapy protocol.
    Idris M; Farid J; Sarwar J; Ahmed S; Wiqar MA; Badsha S
    J Ayub Med Coll Abbottabad; 2010; 22(3):8-11. PubMed ID: 22338406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Acute Lymphoblastic Leukemia: Clinical Characteristics, Treatment Outcomes, and Prognostic Factors: 10 Years' Experience From a Low- and Middle-Income Country.
    Ahmad I; Ghafoor T; Ullah A; Naz S; Tahir M; Ahmed S; Arshad A; Ali A; Khattack TA; Batool F
    JCO Glob Oncol; 2023 Jun; 9():e2200288. PubMed ID: 37290024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
    Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
    Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.